Expertise Partners
Transpharmation
Transpharmation is a contract research organization led by scientists. Recognized by drug developers worldwide for researching and delivering life-changing medicines, science will always remain our passion. We specialize in cross-species and cross-therapeutic areas in translational pharmacology with AAALAC accreditation.
Our breadth of neuroscience expertise means clients are able to benchmark their compounds against clinical gold standards in well validated behavioural and molecular assays and includes PK & non-GLP safety, Pain, Epilepsy, Depression & Anxiety, EEG, Aging, Neurodegenerative Disorders, Biomarkers, Cognitive Disorders and more.
Ulysses Neuroscience
At Ulysses Neuroscience, we stand at the forefront of innovation as your vanguard CRO and translational partner, dedicated to advancing the understanding and treatment of brain disorders. We are committed to accelerating drug discovery programmes of pharmaceutical companies in psychedelics and neuropsychiatric, neurodegenerative, and rare neurodevelopmental disorders by offering cutting-edge clinical and preclinical research services located at Cherrywood Business Park and Trinity College Dublin in the Republic of Ireland.
Our research platforms include therapeutic interventions, access to rare diseased populations, extensive clinical and preclinical molecular biomarker capabilities, in vitro human iPSC rodent and rodent assays, preclinical pharmacological and transgenic rodent models coupled with behavioural and EEG analyses. Guided by our core values of patient-centricity, social responsibility, and a focus on translational research, we are your trusted ally in transforming scientific breakthroughs into tangible treatments.
Program Partner
CHDR: Center for Human Drug Research
The Centre for Human Drug Research (CHDR) is an independent institute that specialises in cutting-edge early-stage clinical drug research. Combining innovative methods and technologies, state-of-the-art facilities, and talented, motivated researchers helps CHDR maximise their clients’ success. In addition, CHDR places the highest priority on their subjects’ comfort and safety, and they play an active role in helping educate the medical and clinical research communities.
Innovation Partner
Eurofins
Eurofins BioPharma Product Testing (BPT) delivers a broad range of harmonized methodologies under GMP authorization and certification. We offer R&D services for method development of analytical methods suitable for GMP Chemistry and Microbiology testing and certification of raw materials and finished products. Our 30,000 ft2 laboratory is equipped with state of the art analytical instrumentation and includes a sterility suite, a wide array of stability chambers as well as an extensive controlled drug substance license and narcotics vault.
Exhibition Partner
Biotrial
Biotrial is a scientifically oriented clinical research organization with 35+ years of experience managing preclinical and clinical CNS studies. The company is comprised of a global team of 350+ employees and physical locations in the US, EU, UK, and Canada. Fully in-house, Biotrial offers In-vivo safety & pharmacology, patient clinical trials support and phase I facilities, as well as core lab, biometrics, and bioanalytical services for biotech and pharma companies. Biotrial expertise in CNS biomarkers -- EEG & qEEG assessments, ERP, PSG, sleep studies, video-oculography, and various cognitive tests is especially strong.
Event Partners
SynapCell
SynapCell is a leader in preclinical efficacy testing in CNS disorders, supporting international
biopharmaceutical companies in identifying their most promising candidates. The translational, objective EEG endpoints we have characterize in translational animal models in vivo have enabled our clients to unlock the true potential of their drugs. Our areas of expertise span from epilepsy to neuropsychiatry and movement disorders. We strongly believe that regular back-and-forth interactions with Sponsor throughout the project is the key to make the most out of an experiment and deliver clear, comprehensive information to help our clients decide on a GO/NO GO decision towards the clinic.
SynapCell
Sama Therapeutics is a precision neuropsychiatry AI/ML platform that synthesizes and validates predictive biomarkers grounded in neural, physiological, multi-omics, natural language, and behavioral phenotypes. The company’s agile SaaS platform, iMAGiNE™, analyzes the transdiagnostic efficacy of pharmaceutical and neurostimulation modalities through precision clinical trials, causal inference, preclinical translation, and generative AI trained on proprietary and open-science datasets. With an extraordinarily interdisciplinary team, Sama Therapeutics is advancing “software as medical device” for a range of indications, including cognitive, affective, interoceptive, and substance use disorders. We
invite partners to join our mission unlocking brain health through integrative neurotechnology and proven “transprognostic” algorithms.
